By Amy Norton, HealthDay Reporter
MONDAY, Oct. 16, 2023 (HealthDay News) — A liver transplant can give people a new lease on life, but at the cost of lifelong immune-suppressing medication and its risks. Now an innovative approach to reduce, or possibly eliminate, certain patients’ reliance on those drugs is showing early promise.
The tactic is aimed at priming a transplant recipient’s immune system to better tolerate liver tissue from a living donor. A week before the transplant, the recipient receives an infusion of specific immune system cells from the donor — ones that, in theory, could tone down any immune system attack on the new “foreign” liver. Read the full article in U.S. News & World Report.